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Mucormycosis is a life-threatening opportunistic infection caused by certain members of
the fungal order Mucorales. This infection is associated with high mortality rate, which can
reach nearly 100% depending on the underlying condition of the patient. Treatment of
mucormycosis is challenging because these fungi are intrinsically resistant to most of the
routinely used antifungal agents, such as most of the azoles. One possible mechanism of
azole resistance is the drug efflux catalyzed by members of the ATP binding cassette
(ABC) transporter superfamily. The pleiotropic drug resistance (PDR) transporter subfamily
of ABC transporters is the most closely associated to drug resistance. The genome of
Mucor circinelloides encodes eight putative PDR-type transporters. In this study,
transcription of the eight pdr genes has been analyzed after azole treatment. Only the
pdr1 showed increased transcript level in response to all tested azoles. Deletion of this
gene caused increased susceptibility to posaconazole, ravuconazole and isavuconazole
and altered growth ability of the mutant. In the pdr1 deletion mutant, transcript level of
pdr2 and pdr6 significantly increased. Deletion of pdr2 and pdr6 was also done to create
single and double knock out mutants for the three genes. After deletion of pdr2 and pdr6,
growth ability of the mutant strains decreased, while deletion of pdr2 resulted in increased
sensitivity against posaconazole, ravuconazole and isavuconazole. Our result suggests
that the regulation of the eight pdr genes is interconnected and pdr1 and pdr2 participates
in the resistance of the fungus to posaconazole, ravuconazole and isavuconazole.
Keywords: Mucor, pleiotropic drug resistance, CRISPR-Cas9, azole, ABC transporterINTRODUCTION
Mucorales species are ubiquitous saprophytes (Hoffmann et al., 2013), but several species are also
known as opportunistic human pathogens, which can cause a life-threatening infection commonly
called as mucormycosis. The most common mucormycosis-causing agent is Rhizopus delemar (also
referred to as R. arrhizus var. delemar and R. oryzae) (Walther et al., 2019), which can causegy | www.frontiersin.org April 2021 | Volume 11 | Article 6603471
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Apophysomyces, Rhizomucor, Mucor and Cunninghamella
species (Prakash and Chakrabarti, 2019). Besides the
pathogenesis of R. delemar, those of Lichtheimia corymbifera
and Mucor circinelloides, have also been studied (Riley et al.,
2016; Skiada et al., 2018; Jeong et al., 2019). Clinical
manifestations of mucormycosis include rhino-cerebral,
pulmonary, cutaneous, and disseminated forms in
immunocompromised patients (Skiada et al., 2018; Jeong et al.,
2019). These infections are generally associated with rapid
progression and high mortality rates (i.e. from 20 to 100%
depending on the underlying condition, the clinical
presentation, and the treatment), furthermore, their diagnosis
and treatment are often difficult (Riley et al., 2016; Skiada et al.,
2018). The immunocompromised state due to malignancy
(Ibrahim et al., 2012; Riley et al., 2016; Skiada et al., 2018) or
immunosuppressive treatments (Bakr et al., 2008; Ibrahim et al.,
2012), diabetic ketoacidosis (Roden et al., 2005; Rammaert et al.,
2012; Roilides et al., 2012), corticosteroid treatment (Prabhu and
Patel, 2004), malnutrition (Sun and Singh, 2011), burn and
trauma (Riley et al., 2016) are the main risk factors for the
infection. For the treatment of mucormycosis, international
guidelines recommend systemic antifungal therapy in
combination with surgical intervention (Caramalho et al.,
2017; Skiada et al., 2018). The first-choice antifungal agent
against Mucorales fungi is amphotericin B. Besides, application
of two triazoles, posaconazole and isavuconazole are approved
for second-line or salvage therapy (Riley et al., 2016). However,
the spectrum of applicable drugs is extremely narrow as these
fungi are intrinsically resistant to most of the routinely used
antifungal agents including most azoles (Almyroudis et al., 2007;
Drogari-Apiranthitou et al., 2012; Riley et al., 2016).
The specific target of azoles is a cytochrome P450 enzyme, the
lanosterol 14a-demethylase enzyme (Cyp51 or Erg11), which
catalyzes an intermediate step of the ergosterol biosynthesis, the
conversion of lanosterol to 4,4-dimethyl-cholesta-8,14,24-
trienol. Ergosterol is the main sterol component of the fungal
cell membrane. Blocking of its synthesis causes accumulation of
toxic 14a-methyl sterols, which alter the stability and
permeability of the cell membrane (Odds et al., 2003).
Development of antifungal resistance is a complex process and
depends on either host- and microbial related factors (White
et al., 1998). In the case of azoles, the resistance mechanisms
most frequently include alterations in ergosterol biosynthetic
enzymes and up-regulation of multidrug transporters (Cowen
et al., 2015).
Expression of drug efflux pumps, which belong to the ATP-
binding cassette (ABC) or the major facilitator superfamily
(MFS) transporters, was found to a major factor contributing
in the fungal resistance to azoles in several human pathogenic
fungi (Prasad and Rawal, 2014; Holmes et al., 2016; Lopez-Ribot
et al., 2017; Sharma and Chowdhary, 2017). In Candida albicans,
two ABC transporters belonging to the pleiotropic drug
resistance (PDR) protein class of ABC transporter superfamily,
Candida drug resistance 1 (Cdr1) and Cdr2 were found to have
the primary role in the azole resistance (Rocha et al., 2017).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2Cdr genes responsible for azole efflux have also been identified
and characterized in other Candida species (Rocha et al., 2017).
Overexpression of the Cryptococcus neoformans antifungal
resistance 1 (AFR1) protein, which also belongs to the PDR
family, led to resistance to fluconazole and an increased virulence
in mouse models (Chang et al., 2018). In the case of Aspergillus
fumigatus, the role of the ABC transporter Cdr1B in itraconazole,
voriconazole and posaconazole resistance was proven (Fraczek
et al., 2013; Hagiwara et al., 2017), but other ABC transporter
genes were also found to be upregulated after azole treatment
(Lopez-Ribot et al., 2017).
Little is known about the background of azole resistance in
mucormycosis-causing fungi. It is assumed that specific amino
acid substitutions in one of the Cyp51 enzymes can affect the
sensitivity of these fungi to several azoles, such as fluconazole or
voriconazole (Caramalho et al., 2017). However, the role of drug
efflux pumps in azole resistance have not been examined in this
fungal group. M. circinelloides belongs to the order Mucorales
and it is a widely used model organism in genetic and molecular
biological studies, among others on light sensing (Corrochano
and Garre, 2010; Vellanki et al., 2018; Yu and Fischer, 2019;
Navarro et al., 2020), molecular regulation and signal processes
(Lee et al., 2015; Ruiz-Vázquez et al., 2015; Calo et al., 2017; Lax
et al., 2020), morphogenesis (Lee et al., 2015; Moriwaki-Takano
et al., 2020; Vellanki et al., 2020), carotenogenesis (Zhang et al.,
2016; Alcalde et al., 2019) and pathogenicity (Li et al., 2011;
López-Fernández et al., 2018; Patiño-Medina et al., 2019). In this
study, transcription of the eight genes of M. circinelloides
possibly encoding PDR-type ABC transporters was analyzed
and three of them (named as pdr1, pdr2 and pdr6) were
knocked out by CRISPR-Cas9 mutagenesis. Using the knock-
out mutants, the effect of these transporters on the azole
resistance was examined.MATERIALS AND METHODS
Strains, Media, and Growth Conditions
Mucor circinelloides strain MS12 (leuA- and pyrG-) (Benito et al.,
1992) was used in the study. For nucleic acid extraction from
Mucor, 106 sporangiospores were plated onto solid minimal
medium (YNB; 10 g glucose, 0.5 g yeast nitrogen base without
amino acids (Sigma-Aldrich), 1.5 g (NH4)2SO4, 1.5 g sodium
glutamate and 20 g agar per liter) supplemented with leucine
and/or uracil (0.5 mg/ml) if required. In some cases, RNA
extraction was performed after cultivation in 30 ml RPMI-1640
without agar (Biosera); the inoculum size was 104
sporangiospores/ml. Fungal cultures were grown for 4 days
under continuous light at 25°C.
To test the effect of azoles on the gene expression, after
cultivating the fungus in 10 ml liquid RPMI-1640 for 24 h at
25°C, it was treated with the corresponding azoles and incubated
for another 16 h before the RNA extraction. Ketoconazole (Alfa
Aesar), itraconazole (Across Organics), fluconazole (Alfa Aesar),
ravuconazole (Sigma Aldrich) and isavuconazole (Sigma
Aldrich) were applied in a final concentration of 8 mg/ml,April 2021 | Volume 11 | Article 660347
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was 2 mg/ml. Anaerobic growth was performed in a BBL GasPak
Anaerobic System (Becton Dickinson) at 25°C. For the antifungal
susceptibility test, Candida krusei ATCC 6258 was used as a
reference strain. After cultivatingMucor in liquid RPMI-1640 for
24 h at 25°C, it was treated with the corresponding azole (i.e.,
ketoconazole, itraconazole, fluconazole, posaconazole,
ravuconazole or isavuconazole), and incubated for another 16 h
before RNA extraction.
To measure the colony diameters of the strains, 104
sporangiospores were inoculated onto the center of solid YNB
plates. The diameter of the colonies was measured daily after
incubating the plates at 25°C using the MS12 strain as the growth
control. In the experiment, we measured the colony diameter of
two colonies using three biological and two technical replicates.
Molecular Techniques
General procedures for plasmid DNA preparation, cloning and
transformation of E. coli DH5a were performed by following
standard methods (Sambrook et al., 1989). Plasmid DNA was
isolated using the PureYield Plasmid Miniprep System (Promega).
Genomic DNA and RNA samples were purified from mycelia
using the ZR Fungal/Bacterial DNA MiniPrepTM (Zymo
Research) and the Quick-RNA MiniPrep kit (Zymo Research),
respectively, according to the manufacturers’ instructions. Genes
were amplified by PCR using the Phusion Flash High-Fidelity
PCR Master Mix (Thermo Scientific) and the primers presented
in Supplementary Table 1. Primer and oligonucleotide
sequences were designed using the M. circinelloides
CBS277.49v2.0 genome database (DoE Joint Genome Institute;
http://genome.jgi-psf .org/Mucci2/Mucci2.home.html)
(Corrochano et al., 2016).
Sequence Analysis
Sequencing was commercially performed by LGC Genomics
(Berlin, Germany). Amino acid sequences obtained from M.
circinelloides CBS277.49v2.0 genome database and Cryptococcus
neoformans Afr1 (UniProtKB: Q8X0Z3) were aligned using the
ClustalW program (Higgins et al., 1996). BLAST searches were
performed at the site of the National Center for Biotechnology
Information (NCBI) (https://blast.ncbi.nlm.nih.gov/Blast.cgi.
Programs used to analyze the amino acid sequences of the
putative PDR proteins were accessed throught the Swiss Expasy
Server (http://www.expasy.ch) (Gasteiger et al., 2005). Domain
search and prediction were performed using the Motif Scan
(MyHits) program (Pagni et al., 2007).
Homologous sequences of Cryptococcus neoformans var.
neoformans JEC21 AFR1 were searched on the JGI MycoCosm
portal (https://mycocosm.jgi.doe.gov/mycocosm/home)
(Grigoriev et al., 2014). Sequences with at least 50% identity
were retrieved and hits from non-public genomes were removed.
The remaining sequences were clustered by using MMseqs2 v.
bbd564172bd55d9e6acd1170e59790c37157a21b (Steinegger and
Söding, 2017). The sensitivity of the cascaded clustering was set to
7.5 applying the cluster reassign mode. Maximum Likelihood
analysis was conducted with the cluster comprising of 853
sequences including the AFR1 protein and the 8 examined PDRFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3proteins from M. circinelloides CBS 277.49 (for the sequences
included see Supplementary Table 2). Sequences were aligned
using MAFFT v. 7.453 (Katoh and Standley, 2013) with the E-
INS-i iterative refinement method. Poorly aligned regions were
removed by using trimAl v. 1.2rev57 (Capella-Gutierrez et al.,
2009) with the -automated1 option. Phylogenetic reconstruction
was carried out by using IQ-TREE v. 1.6.12 (Nguyen et al., 2015)
with the LG4M+R6 model determined by the inbuilt model
selection tool (Kalyaanamoorthy et al., 2017). Branch supports
were calculated with 5000 ultrafast bootstrap (Hoang et al., 2018).
Real-Time Quantitative Reverse
Transcription PCR Analysis
Reverse transcription was carried out with the Maxima H Minus
First Strand cDNA Synthesis Kit (Thermo Scientific) using
random hexamer and oligo (dT)18 primers, following the
instructions of the manufacturer. The qRT-PCR experiments
were performed in a CFX96 real-time PCR detection system
(Bio-Rad) using the Maxima SYBR Green qPCR Master Mix
(Thermo Scientific) and the primers presented in Supplementary
Table 1. The relative quantification of the copy number and the
gene expression was achieved with the 2-DDCt method (Livak and
Schmittgen, 2001) using the actin gene of M. circinelloides as a
reference (Nagy et al., 2014). Experiments were performed in
biological and technical triplicates.
Design of the gRNAs and Construction of
the Disruption Cassettes to Disrupt the
pdr Genes by the CRISPR-Cas9 Method
The protospacer sequences designed to target the DNA cleavage
in pdr1 (CBS277.49v2.0 genome database Protein Id: 48059),
pdr2 (CBS277.49v2.0 genome database Protein Id: 83305) and
pdr6 (CBS277.49v2.0 genome database Protein Id: 146716) genes
were the followings, 5′- tttatgaacttgtgtatgaa - 3′, 5′- tgctgatttc
gagcgtatcac -3′ and 5’- ctatattgctcaagtcatca -3’, respectively.
Using these sequences, the Alt-R CRISPR crRNA and Alt-
RCRISPR-Cas9 tracrRNA molecules were designed and
purchased from Integrated DNA Technologies (IDT). To form
the crRNA:tracrRNA duplexes (i.e. the gRNAs), the Nuclease-
Free Duplex Buffer (IDT) was used according to the instructions
of the manufacturer. Genome editing strategies followed the set-
up described earlier (Nagy et al., 2017). Homology direct repair
(HDR) was applied for all gene disruptions following the strategy
described previously (Nagy et al., 2017). Disruption cassettes
functioning also as the template DNA for the HDR were
constructed by PCR using the Phusion Flash High-Fidelity
PCRMaster Mix (Thermo Scientific). At first, two fragments,
upstream from start codon and downstream from stop codons of
the targeted gene and the M. circinelloides pyrG gene
(CBS277.49v2.0 genome database Protein Id: 36136) or M.
circinelloides leuA gene (CBS277.49v2.0 genome database
Protein Id: 33992) along with its own promoter and terminator
sequences were amplified using gene specific primer pairs (see
Supplementary Table 1). The amplified fragments were fused in
a subsequent PCR using nested primers (see Supplementary
Table 1); the ratio of the fragments in the reaction was 1:1:1.April 2021 | Volume 11 | Article 660347
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Used to Complement the Deletion of the
pdr1 Gene
The leuA gene (CBS277.49v2.0 genome database ID:
Mucci.e_gw1.2.132.1) using gene specific primers was
amplified from the genomic DNA of the MS12 strain
(Supplementary Table 1) and ligated into pJET1.2/blunt
plasmid (Thermo Scientific) to create the plasmid pJet+leuA.
The pdr1 gene was amplified together with its own promoter and
terminator regions using gene specific primers (Supplementary
Table 1) and the resulting fragment was also ligated into pJet1.2/
blunt vector to create the plasmid pJet+pdr1. Then, pdr1 together
with its regulatory regions was cut from this plasmid by the
enzyme NotI and ligated at the same restriction site of pJet+leuA
to construct pPdr1compl plasmid (Supplementary Figure 1A).
This plasmid was used to introduce to the MS12- Dpdr1 to create
MS12-Dpdr1+pPdr1compl strains. The complemented pdr1 gene
was amplified by PCR using Mc48059P7 and Mc48059P8
primers (Supplementary Figure 1B and Supplementary
Table 1).
Transformation Experiments
For the CRISPR-Cas9-mediated gene knock out and the
complementation of the Dpdr1 gene, the PEG-mediated
protoplast transformation method was used according to van
Heeswijck and Roncero (1984). Protoplasts were prepared as
described earlier (Nagy et al., 1994). For the gene disruption by
CRISPR-Cas9 method, 5 mg template DNA (disruption cassette),
10 mM gRNA and 10 mM Cas9 nuclease were added to the
protoplasts in one transformation reaction as described by Nagy
et al. (2019). To complement the deletion of the pdr1, 5 mg
pPdr1compl plasmid DNA was added into one transformation
reaction. In each case, transformants were selected on solid YNB
medium by the complementation of the uracil and/or leucine
auxotrophy of the MS12 strain. From each primary
transformant, monosporangial colonies were formed under
selective conditions. Deletion of genes was confirmed by
sequencing in all cases while the absence of the transcripts of
the deleted genes was proven by qRT-PCR.
Measurement of Energy-Dependent
Rhodamine 6G Efflux
Measurement of R6G efflux was analyzed according to Gbelska
et al. (2017). Sporangiospores of the strains (107) were inoculated
in 10 ml YNB and incubated in a fridge for 16 h. The spores were
then incubated for 4 h at 25°C under continuous shaking at 220
rpm. Germinating spores were collected by centrifuging the
samples for 10 min at 4°C at 2000×g. The pellets were washed
two times with ice-cold PBS buffer and 2-deoxy-D-glucose and
R6G were added to the cells in final concentrations of 2 mM and
100 µM, respectively. Fungal cells were incubated for 2 h at 25°C
in dark, washed two times with ice cold PBS and finally
resuspended in PBS. Then, D-glucose were added to the
samples, in a final concentration of 2 nM. After incubation for
10, 20 and 30 min, 400 µl of the samples were centrifuged forFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 42 min at 8000×g and 100 µl of the supernatants were transferred
into a 96-wells black plate. The fluorescence signal was measured
using a fluorimeter (FLUOstar OPTIMA, BMG Labtech) where
the excitation filter was 520BP1 and the emission filter was 590-
10. Experiments were performed in biological and technical
triplicates. To determine the R6G concentration, a standard
curve was generated using the following concentrations: 0, 100,
250, 500 and 1000 nM.
Susceptibility Tests
Sensitivity of the fungal strains to different antifungal agents, and
H2O2 was examined in a 96-well microtiter plate assay. The
susceptibility test was performed according to the CLSI
recommendation (Rex and Clinical, 2008) in three biological
repl icates . Ketoconazole (Alfa Aesar) , i traconazole
(Across Organics), fluconazole (Alfa Aesar), ravuconazole
(Sigma Aldrich), posaconazole (Sigma Aldrich), isavuconazole
(Sigma Aldrich), amphotericin B (Sigma Aldrich), hygromycin
B (Sigma Aldrich), terbinafine (Sigma Aldrich), micafungin
(Sigma Aldrich) and cyclohexymide (PanReac AppliChem)
were dissolved in DMSO to prepare the stock. These stocks
were then diluted with liquid RPMI-1640 medium. Final
concentrations of ketoconazole, itraconazole, fluconazole,
terbinafine and micafungin in the wells ranged from 0.125 to
64 mg/ml while those of ravuconazole and isavuconazole ranged
from 0.125 to 16 mg/ml. In the case of posaconazole and
amphoter ic in B, the range was 0.125 to 8 mg/ml .
Cyclohexymide were diluted in RPMI-1640 to obtain a range of
250-0,78 mg/ml. Hydrogen peroxide was diluted in liquid RPMI-
1640 to prepare a stock solution of 100 mM. Final concentrations
of the hydrogen peroxide in the wells ranged from 0 to10 mM.
Inocula were prepared and diluted in liquid RPMI-1640. Plates
were incubated for 48 h at 25°C.
Statistical Analysis
All measurements were performed in at least two technical and
three biological replicates. Significance was calculated with
paired t-test or One-way Anova using the Graph Pad Prism 7
program. P values less than 0.05 were considered as
statistically significant.RESULTS
Characteristic Features of PDR Proteins
of Mucor circinelloides
In the M. circinelloides genome database (DoE Joint Genome
Institute; M. circinelloides CBS277.49v2.0; http://genome.jgi-psf.
org/Mucci2/Mucci2.home.html), eight potential PDR proteins
were found by amino acid similarity search using the amino acid
sequence of Cryptococcus neoformans Afr1 (UniProtKB:
Q8X0Z3) and Candida albicans Cdr1p (UniProtKB: P43071).
The identity of amino acid sequences was between 36.8 and
39.6%. Despite the low identity values, the characteristic motifs
of the 8 putative Pdr proteins could be identified. Protein ID,April 2021 | Volume 11 | Article 660347
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putative PDR proteins, the amino acid motifs characteristic to
the PDR family, such as the first and second Walker-A and B
sequences, the first and second ABC signature motifs (Posteraro
et al., 2003) and the conserved PDR specific NBD1
(T/SL/FLK/RT/V/II/L) and NBD2 (TLLN/DC/VL/R) motifs
(Rawal et al., 2016) were identified (Supplementary Figure 2).
PDR/CDR ABC motifs (Gauthier et al., 2003) were also
identified in all eight putative PDR proteins using the motif
scan (MyHits) program (Table 1).
Comparing the amino acid sequences,PDR6 and PDR7
proved to be the most similar proteins followed by PDR2 and
PDR5 showing an amino acid identity of 82.79 and
82.49%, respectively.
A phylogeny was inferred from 853 amino acid sequences of
PDR proteins representing the five main fungal phyla. A
simplified view of the resulting tree is shown in Figure 1 while
the whole version can be found in Supplementary Figure 3. On
this tree, PDR transporters of fungi belonging to the
Chytridiomycota, Zoopagomycota and Mucoromycota
(including the examined PDR1-8 of M. circinelloides) can be
found in the clades, which clearly correspond to the phylogenetic
position of these fungal groups. At the same time, Ascomycota
and Basidiomycota sequences grouped together in various clades
corresponding to different subfamilies of PDR proteins. Our
results support the monophyly of Mucoromycota PDR proteins,
which form a sister group of the Dicarya PDRs. Within the latter
group the clade containing the C. neoformans Afr1 protein
proved to be the closest to the Mucoromycota clade. Within
the Mucoromycota clade, two main clades can be discriminated,
among which the clade A contains theM. circinelloides PDR1, 6,
7 and 8 proteins while the clade B includes PDR2, 3, 4 and 5.
Within the two main clades, proteins of a same species can be
positioned in various subclades indicating several gene
duplications and a diversification of the pdr genes in this
fungal group.
Relative Transcript Levels of the pdr
Genes After Azole Treatment
In general, pdr genes responded differently to the tested azoles
(Figure 2). Itraconazole had the widest effect on pdr expression
upregulating five of the eight genes, i.e., pdr1, pdr2, pdr3, pdr5
and pdr6. Three genes (pdr1, pdr5 and pdr6) displayed increasedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5transcript levels in response to ketoconazole, while fluconazole
treatment resulted in increased transcript level for pdr1, pdr3,
pdr4 and pdr7. Transcript level of pdr1, pdr2, pdr3 and pdr5
increased significantly after isavuconazole treatment. From the
eight genes, only pdr1 had significantly increased transcript levels
in response to all azoles (Figure 2). Interestingly only this gene
responded with higher transcript level to posaconazole.
Treatments with ketoconazole, itraconazole, fluconazole,
posaconazole and ravuconazole resulted in decreased transcript
levels for pdr7 and pdr8. Pdr4 only responded to treatment with
fluconazole and ravuconazole, while the pdr6 transcript level
significantly increased after ketoconazole and itraconazole
treatments. A heat-map was generated to summarize the result
of the qRT-PCR experiments (Figure 3). It can be seen that pdr1,
pdr3, pdr4 and pdr6 are generally upregulated in response to
azole treatments while pdr2, pdr5 and especially pdr7 and pdr8
are rather downregulated by the azoles.
Relative Transcript Levels of pdr Genes
Under Anaerobic Condition
Morphological dimorphism is a characteristic feature of M.
circinelloides. In the absence of oxygen, filamentous growth of
the fungus switches to a yeast-like form. MS12 was grown in
liquid RPMI-1640 at 25°C for 24 h. Then, the culture was
transferred into an oxygen-free environment containing 10%
CO2. RNA was extracted after incubating the fungus
anaerobically for 240 min. Pdr1 and pdr3 displayed
significantly decreased transcript levels under anaerobiosis
compared to their transcript levels measured in aerobic
environment (Figure 4). Contrarily, the transcript level of pdr5
significantly increased under anaerobiosis (Figure 4).
Knock Out of the pdr1 Gene Using the
CRISPR-Cas9 Method
Based on the qPCR experiment, deletion of pdr1 gene was
assigned for gene knock out by using the CRISPR-Cas9
technique. For deletion of pdr1, transformation and the
genome editing frequencies were 4/105 protoplasts and 100%,
respectively, as demonstrated by PCR analysis of the isolated
colonies amplifying the expected fragments (Supplementary
Table 3, Supplementary Figure 4). Mutants proved to be
mitotically stable retaining the integrated fragment even after







Position of NBD1 Position of NBD2
48059 PDR1 scaffold_03:2555182-2559793 (-) 1416 aa 667-805 aa 146-151 aa 831-837 aa
83305 PDR2 scaffold_06:2898818-2903484 (+) 1481 aa 737-872 aa 217-222 aa 898-904 aa
141912 PDR3 scaffold_04:1521204-1525513 (-) 1415 aa 669-807 aa 155-160 aa 833-839 aa
142239 PDR4 scaffold_04:2922648-2927179 (-) 1441 aa 698-833 aa 183-188 aa 859-865 aa
145852 PDR5 scaffold_06:2231882-2236192 (+) 1371 aa 628-763aa 108-113 aa 789-795 aa
146716 PDR6 scaffold_06:2892916-2897373 (+) 1384 aa 636-774 aa 115-120 aa 800-806 aa
158611 PDR7 scaffold_01:3472584-3477196 (-) 1463 aa 725-863 aa 193-198 aa 878-884 aa
186086 PDR8 scaffold_01:475770-480189 (-) 1349 aa 601-739 aa 80-85 aa 765-771 aaApril 2021 | Volume 11 | Article 660347
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further experiments.
Relative Transcript Levels of the Intact pdr
Genes in the Dpdr1 Knock Out Mutants
qRT-PCR analysis proved the absence of the transcript of the
deleted pdr1 gene and revealed that the relative transcript levels
of pdr2 and pdr6 changed significantly in the mutant
(Figure 5A).
Deletion of pdr2 and pdr6 and Creation of
Dpdr1-Dpdr2 and Dpdr1-Dpdr6 Double
Knock out Mutants
Based on the qRT-PCR analysis of the MS12-Dpdr1 mutant
strain, deletion of pdr2 and pdr6 gene was performed using the
CRISPR-Cas9 system to create single and double mutants. For
the MS12-Dpdr2 and MS12-Dpdr6 s ingle mutants ,
transformation frequencies were 12 and 10 colonies per 105
protoplasts, respectively while the genome editing efficiency was
83% and 100%, respectively (Supplementary Table 3,
Supplementary Figure 5). To create Dpdr1-Dpdr2 -and Dpdr1
Dpdr6 double mutants, MS12-Dpdr1 was used as the recipient
strain. Transformation frequency was 8 and 3 colonies and the
genome editing efficiency was 75% and 66.66% for MS12-Dpdr1-
Dpdr2 and MS12-Dpdr1-Dpdr6, respectively (Supplementary
Table 3). Two isolates from each the transformation
experiments were analyzed by PCR and the expected fragments
were amplified (Supplementary Figure 6).
Relative Transcript Levels of the Intact pdr
Genes in the MS12-Dpdr2 and MS12-Dpdr6
Single-, and the MS12-Dpdr1-Dpdr2 and
MS12-Dpdr1-Dpdr6 Double Knock Out
Mutants
qRT-PCR analysis proved the absence of the transcripts of the
deleted genes in all mutants. It also revealed that the transcript
level of pdr3 and pdr4 significantly decreased in the MS12-Dpdr2
strain (Figure 5B). At the same time, deletion of the pdr6 gene
led to significantly increased relative transcript levels for pdr1,
pdr7 and pdr8, while the relative transcript level of the other pdr
genes significantly decreased (Figure 5C).
After simultaneous deletion of pdr1 and pdr2, the transcript
level of pdr8 significantly increased in the mutants (Figure 5D).
In the MS12-Dpdr1-Dpdr6 mutant, the transcript levels of pdr2,
pdr3, pdr5, pdr7 significantly increased, while those of pdr4 and
pdr8 significantly decreased (Figure 5E).
Effect of the pdr1, pdr2, and pdr6 Gene
Deletions on the Colony Growth of the
Mutant Strains
Colony growth of the single (i.e., MS12-Dpdr1, MS12-Dpdr2 and
MS12-Dpdr6) and double pdr mutants (i.e., MS12-Dpdr1-Dpdr2
andMS12-Dpdr1-Dpdr6) significantly decreased compared to the
parental MS12 strain on the third and fourth days of cultivation
(Figure 6). When deletion of the pdr1 gene was complemented
by transforming pPdr1compl plasmid into the MS12-Dpdr1FIGURE 1 | Phylogenetic tree of PDR proteins inferred from 853 amino acid
sequences using Maximum Likelihood method. The eight M. circinelloides Pdr
proteins, C. neoformand CnAfr1 and the C. albicans Cdr1 and Cdr2 are
indicated with bold characters. Numbers above or below branches are
ultrafast bootstrap supports. Only values greater than 95% are shown.April 2021 | Volume 11 | Article 660347
Nagy et al. Pdr Genes of Mucor circinelloidesFIGURE 2 | Relative transcript levels of the pdr genes of M. circinelloides after azole treatment. MS12 was grown in RPMI-1640 liquid media at 25°C; transcript level
of each gene measured in the untreated control was taken as 1. The presented values are averages of three independent experiments; error bars indicate standard
deviation. Relative transcript values followed by * and ** significantly differed from the untreated control according to the paired t-test (*p < 0.05 and **p < 0.01).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org April 2021 | Volume 11 | Article 6603477
Nagy et al. Pdr Genes of Mucor circinelloidesstrain, growth ability of the resulting MS12-Dpdr1+pPdr1compl
strain proved to be similar to that of the original MS12 strain
(Figure 6A).
Measurement of the R6G Efflux Activity of
the Tested Strains
To examine the drug efflux activity of the strains, R6G efflux
in the parental and the pdr mutant strains were compared.
Twenty min after R6G uptake, MS12-Dpdr1 and MS12-Dpdr2
mutants showed significantly decreased efflux activity than
the parental strain (Figure 7). After 30 min, efflux activity of
all mutants, except MS12-Dpdr6, significantly decreased
(Figure 7).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8Effect of the Gene Knock Out on the
Susceptibility to Different Antifungal
Agents and Hydrogen Peroxide Under
Aerobic and Anaerobic Conditions
Sensitivity of the MS12-Dpdr1, MS12-Dpdr2, MS12-Dpdr6,
MS12-Dpdr1-Dpdr2 and MS12-Dpdr1-Dpdr6 mutants and the
MS12 strain were determined to different antifungal agents and
hydrogen peroxide (H2O2) by using the broth microdilution
method under aerobic and anaerobic conditions and the minimal
inhibitory concentration (MIC) of different azoles was
determined. Sensitivity of the mutants did not differ from that
of the original MS12 strain to amphotericin B, hygromycin B,
terbinafine, micafungin, ketoconazole , fluconazole ,
cycloheximide and H2O2 under both aerobic and anaerobic
conditions. All mutants showed, however, increased
susceptibility to posaconazole and ravuconazole, while knock
out of pdr1 resulted in increased sensitivity to isavuconazole
under anaerobic condition as well (Table 2). After
complementation of the pdr1 deletion, susceptibility of MS12-
Dpdr1+pPdr1compl strains to all tested azoles was similar to that
of the original MS12 strain.
Under anaerobic condition, knock out of pdr2 resulted in
decreased sensitivity to ketoconazole compared to the parental
strain, while susceptibility of the MS12-Dpdr1 and MS12-Dpdr2
mutants increased to itraconazole, ravuconazole and
isavuconazole. Deletion of pdr1 and pdr2 had no effect on the
sensitivity to posaconazole under anaerobiosis. Knock out of
pdr6 had no effect on the susceptibility to the different azoles at
all under anaerobiosis (Table 3).DISCUSSION
Treatment of mucormycosis is looked upon as challenging and
aggravated by the fact that Mucorales species are resistant to most
azole antifungals. The molecular mechanism of their innate
resistance to short-tailed azoles was described, but yet not
completely clarified (Caramalho et al., 2017). ResistanceFIGURE 3 | Heat-map of transcript level of pdr genes in response to exposure to azoles. Red and green colors indicate down- and upregulation, respectively, while
yellow corresponds to the transcription activity of the control.FIGURE 4 | Relative transcript levels of pdr genes under anaerobic
condition. Transcript level of each gene was measured under aerobic
condition was taken as 1. The presented values are averages of three
independent experiments; error bars indicate standard deviation. For
RNA extraction, fungal strains were cultivated on YNB for two days at
25°C. Relative transcript values followed by * and ** significantly differed
from the value taken as 1 according to the paired t-test (*p < 0.05 and
**p < 0,01).April 2021 | Volume 11 | Article 660347
Nagy et al. Pdr Genes of Mucor circinelloidesmechanisms of various Candida and Aspergillus species have been
characterized with more details (Cuenca-Estrella, 2014). The main
target of azoles is the lanosterol-demethylase enzyme (i.e. Cyp51
or Erg11), which plays a crucial role in the ergosterol biosynthesis
of yeasts and molds (Monk et al., 2020). Overexpression of and
point mutations in the cyp51 gene can cause increased resistance
to different azoles used in the clinic and agriculture (Parker et al.,
2014). Besides lanosterol-demethylase, ABC- and MFS
transporters are involved in the mechanism of azole resistance
(Fraczek et al., 2013; Cuenca-Estrella, 2014; Gonçalves et al., 2016;
Rocha et al., 2017). In C. albicans, the MFS-transporter MDR1
contribute to the fluconazole, voriconazole and ketoconazole
resistance (Morschhäuser, 2010), but does not confer resistance
to posaconazole, isavuconazole or itraconazole (Sanglard and
Coste, 2015).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 9ABC transporters constitute one of the largest transporter
superfamily. These proteins often consist of multiple subunits
(i.e., of the transmembrane domain [TMD] and the nucleotide
binding domain [NBD]). The transport is driven by ATP
hydrolysis (Wilkens, 2015). ATP is the substrate of NBD,
which has some conserved motifs, such as Walker-A, Walker-
B and the ABC-signature (Seeger and van Veen, 2009; Lamping
et al., 2010; Holmes et al., 2016). The sequence of TMD is more
diverse reflecting to the diversity of the transported substrate
(Seeger and van Veen, 2009). Within the ABC transporters, the
PDR subfamily is the most closely associated to drug resistance
(Cannon et al., 2009). In the M. circinelloides genome database,
eight putative PDR transporter coding genes were identified. The
abovementioned motifs characteristic to ABC transporters were





FIGURE 5 | Relative transcript levels of pdr genes in the MS12-Dpdr1/1 (A), MS12-Dpdr2 (B), MS12-Dpdr6 (C) MS12-Dpdr1-Dpdr2 (D) and MS12-Dpdr1-Dpdr6
(E) mutant compared to that in the original strain. Transcript level of each gene measured in the strain MS12 (black column) was taken as 1. The presented values
are averages of three independent experiments (error bars indicate standard deviation). For RNA extraction, fungal strains were cultivated on YNB for two days at
25°C. Relative transcript levels significantly different from the value taken as 1 according to the paired t-test are indicated with * or ** (*p < 0.05, **p < 0.01).April 2021 | Volume 11 | Article 660347
Nagy et al. Pdr Genes of Mucor circinelloidesAnalysis of the promoter regions of the eightMucor genes did
not reveal the presence of the motifs described as PDRE (TCCG/
aC/tGG/cA) or CDRE (CGGA(A/T)ATCGGATATTTTTTTT)
elements. These motifs were originally found and characterized
in Saccharomyces (Mamnun et al., 2002) and Candida (de
Micheli et al., 2002) as the binding sites of transcription factors
regulating the expression of the pdr genes. If such binding sites
are present, the consensus sequences established for Ascomycota
cannot be applied to find them, maybe because of the large
evolutionary distance.
Phylogenetic analysis of PDR transporters indicated the
monophyly of Mucoromycota PDRs; although, within the
Mucoromycota clade various gene duplication events can be
assumed. Based on a phylogenetic analysis of 78 PDR proteins,
Lamping et al. (2010) previously discerned 10 clades of PDR
transporters within the Dicarya, among which four clades (i.e.
clades B, G, H1a and H1b) contained PDRs of both AscomycotaFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10and Basidiomycota fungi. None of the involved Mucoromycota
sequences grouped together with any of the Dikarya PDRs.
Mucor pdr genes show similarity to the C. neoformans Afr1
gene, which was also strengthen by the phylogenetic analysis of
the fungal PDR genes Afr1 is involved in the resistance of
Cryptococcus to fluconazole (Sanguinetti et al., 2006).
Overexpression of Afr1 increased the azole resistance
indicating that upregulation of the gene may play a role in the
fluconazole resistance (Posteraro et al., 2003; Sanguinetti et al.,
2006; Morschhäuser, 2010). In our experiments, transcription
level of allM. circinelloides pdr genes altered after treatment with
either of the tested azoles, although only that of the pdr1
increased in response to all of them.
Mucorales species are generally resistant to fluconazole and
voriconazole, while isavuconazole and itraconazole were found
to have in vitro species-specific activity (Dannaoui, 2017).





FIGURE 6 | Colony diameters of the pdr deletion mutants and the original MS12 strain of Mucor circinelloides at 25°C on YNB medium. (A) shows the colony
diameter of pdr1 deleted and complemented strains, (B, C) show the colony diameter of the single pdr2 and pdr6 knock out mutants, while (D, E) show the colony
diameter of the double knock out strains. The presented values are averages; colony diameters were measured during three independent cultivation (error bars
indicate standard deviation). Values followed by * and ** significantly differed from the corresponding value of the MS12 strain according to the two-way Anova
(*p < 0.05; **p < 0.01).April 2021 | Volume 11 | Article 660347
Nagy et al. Pdr Genes of Mucor circinelloidessuggest first-line antifungal therapy with lipid formulations of
amphotericin B (AMB), whereas posaconazole (Cornely et al.,
2014) is recommended and isavuconazole (Ashkenazi-Hoffnung
et al., 2020) was successfully used as salvage therapy. In our
study, posaconazole treatment affected the transcription of pdr1
only while isavuconazole significantly increased the transcript
level of pdr1, pdr2, pdr3 and pdr5.
Deletion of pdr1 increased the sensitivity of the mutants to
posaconazole and isavuconazole. Although it was found to be
upregulated by isavuconazole, deletion of pdr2 did not affect the
susceptibility to this compound. At the same time, MS12-Dpdr2
mutants showed increased susceptibility to posaconazole
similarly to the MS12-Dpdr1 strains.
Fluconazole treatment affected the transcription of various
genes including pdr1 but neither single nor double deletionFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11mutants generated in this study displayed altered susceptibility
to this drug. This result is in agreement with the observations
that, in addition to active transport mechanisms, alterations in
the lanosterol-demethylase gene (Edlind et al., 2001; Sionov et al.,
2012; Leonardelli et al., 2016; Caramalho et al., 2017) and/or a
novel Zn2-Cys6 transcription factor may also underlie the
fluconazole resistance of these fungi (Hagiwara et al., 2017).
qRT-PCR analysis revealed highly similar transcription
patterns for pdr1 and pdr6 after azole treatment. At the same
time, deletion of pdr1 caused significantly increased transcript
level of pdr2 and pdr6, while the relative transcript level of pdr1,
pdr7 and pdr8 significantly increased in the MS12-Dpdr6mutant.
These results suggest that regulation of pdr genes is highly
interconnected and coordinated. It can also be assumed that
the increased activity of certain pdr genes may compensate theFIGURE 7 | Measurement of the R6G efflux activity. After uptake of rhodamine 6G, fungal cells were resuspended in PBS supplemented with 2 nM of D-glucose.
Values followed by * and ** significantly differed from the corresponding value of the MS12 strain according to the two-way Anova (*p < 0.05; **p < 0.01), n.s. is
non-significant.TABLE 2 | Minimal inhibitory concentrations (MIC) of the azoles (µg/ml) against the mutants and the parental M. circinelloides MS12 strain under aerobic condition.
MIC (µg/ml)
Strain Ketoconazole Itraconazole Fluconazole Posaconazole Ravuconazole Isavuconazole
MS12 >64 >64 >64 4 16 >16
MS12-Dpdr1/1 >64 >64 >64 2 4 16
MS12-Dpdr1/2 >64 >64 >64 2 8 8
MS12-Dpdr1+pPdr1compl/1 >64 >64 >64 4 >16 >16
MS12-Dpdr1+pPdr1compl/2 >64 >64 >64 4 16 16
MS12-Dpdr2/1 >64 >64 >64 2 16 >16
MS12-Dpdr2/2 64 >64 >64 2 8 >16
MS12-Dpdr6/1 >64 >64 >64 4 16 (MIC50) 16 (MIC50)
MS12-Dpdr6/2 >64 >64 >64 4 16 (MIC50) 16 (MIC50)
MS12-Dpdr1- Dpdr2/1 >64 >64 >64 2 8 16
MS12-Dpdr1- Dpdr2/2 >64 >64 >64 2 16 16
MS12-Dpdr1- Dpdr6/1 >64 >64 >64 2 8 16
MS12-Dpdr1- Dpdr6/2 >64 >64 >64 2 8 16April 2021 | Volume 11 | Article 660347
Nagy et al. Pdr Genes of Mucor circinelloideslack of the deleted genes. A similar phenomenon was previously
described for the three HMG-CoA reductase isogenes in M.
circinelloides (Nagy et al., 2019). Functional linkages of genes
involved in antifungal resistance was observed in Saccharomyces
cerevisiae where deletion of two multidrug transporter genes,
yor1 and snq2 caused an increased expression of pdr5, while the
lack of pdr5 and snq2 induced yor1 expression (Kolaczkowska
et al., 2008).
Susceptibility testing of the deletion mutants suggests that
pdr1 and pdr2 may have role in the protection from the effect of
posaconazole, isavuconazole and ravuconazole and this function
is affected by the oxygen level of the environment. At the same
time, deletion of pdr6 had no significant effect on the azole
resistance of the fungus. Deletion of pdr1 and pdr2 resulted
decreased efflux activity in all tested mutant strains, while the
efflux activity of MS12-Dpdr6 strain was similar to the parental
MS12 strain.
Our results suggest that the tested pdr genes involved in
different degrees in the resistance to the different azoles. In C.
glabrata Cdr1 and Cdr2 also had a different effect on the
resistance to azoles (Sanglard et al., 2001). In A. fumigatus
deletion of abcA and abcB/cdr1B transporters, which show the
highest similarity to S. cerevisiae pdr5, resulted in increased
susceptibility to voriconazole, but this effect was more
pronounced in case of the DabcB/cdr1B mutant (Paul et al.,
2013). In Aspergillus oryzae, deletion of atrG belonging to the
PDR subfamily, caused increased azole susceptibility, while its
simultaneous deletion with atrA conferred azole hypersensitivity
(Miura et al., 2018).
In the absence of oxygen, filamentous growth of M.
circinelloides switches to a yeast-like form and the fungus
produces energy by fermentation (Nagy et al., 2014). These
morphological and metabolic changes are necessary associated
to serious changes in the expression of numerous genes.
Transporters and other membrane associated proteins are
expected to be affected by these processes. Under anaerobic
condition, the transcript levels of pdr1 and pdr4 decreased,
while the transcript level of pdr5 increased significantlyFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12compared to the aerobic condition. The transcript levels of
other pdr genes did not change significantly. The growth ability
of the created mutants somewhat decreased compared to the
parental strain. This phenomenon can be explained by the fact
that the function of PDR transporters in not limited to the drug
export. In S. cerevisiae Aus1p and Pdr11p are required for
import of exogenous sterols for anaerobic growth (Wilcox et al.,
2002; Reiner et al., 2006; Kohut et al., 2011; Zavrel et al., 2013)
and simultaneous disruption of the encoding genes proved to
be lethal under anaerobiosis (Wilcox et al., 2002). S. cerevisiae
Pdr5 and Yor1 play role in the externalization of lipids
(Decottignies et al., 1998; Pomorski et al., 2003). In C.
albicans, Cdr1 plays role in the drug efflux and, along with
Cdr2 and Cdr3, involved in the externalization of lipids (Smriti
et al., 2002; Tsao et al., 2009).CONCLUSION
M. circinelloides has eight genes encoding PDR transporters.
Transcription analysis of these genes suggests that their
regulation is interconnected and affected by the different
azoles. The genes pdr1 and pdr2 seem to participate in the
resistance or reduced sensitivity to posaconazole, ravuconazole
and isavuconazole. It is also clear, that resistance to these azoles
and azole resistance in general cannot be completely explained
by the activity of the tested PDR proteins. Other mechanisms,
such as special regulatory processes, multiple transporter genes
and alterations in the lanosterol-demethylase gene might also
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Thw yeast zinc finger regulators Pdr1p and Pdr3p control pleiotropic drug
resistance (PDR) as homo- and heterodimers in vivo.Mol. Microbiol. 45, 1429–
1440. doi: 10.1046/j.1365-2958.2002.03262.x
Miura, D., Sugiyama, K., Ito, A., Ohba-Tanaka, A., Tanaka, M., Shintani, T., et al.
(2018). The PDR-type ABC transporters AtrA and AtrG are involved in azole
drug resistance in Aspergillus oryzae. Biosci. Biotechnol. Biochem. 82, 1840–
1848. doi: 10.1080/09168451.2018.1497941
Monk, B. C., Sagatova, A. A., Hosseini, P., Ruma, Y. N., Wilson, R. K., and Keniya,
M. V. (2020). Fungal Lanosterol 14a-demethylase: A target for next-generation
antifungal design. Biochim. Biophys. Acta (BBA) - Proteins Proteomics 1868,
140206. doi: 10.1016/j.bbapap.2019.02.008
Moriwaki-Takano, M., Iwakura, R., and Hoshino, K. (2020). Dimorphic
mechanism on cAMP mediated signal pathway in Mucor circinelloides.
Appl. Biochem. Biotechnol. doi: 10.1007/s12010-020-03342-6
Morschhäuser, J. (2010). Regulation of multidrug resistance in pathogenic fungi.
Fungal Genet. Biol. 47, 94–106. doi: 10.1016/j.fgb.2009.08.002
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